TY  - GEN
TI  - Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
SN  - 0098-7484
PY  - 1995///0130
KW  - Aged
KW  - Cholesterol, HDL
KW  - blood
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Endometrial Hyperplasia
KW  - chemically induced
KW  - Estrogen Replacement Therapy
KW  - Estrogens, Conjugated (USP)
KW  - administration & dosage
KW  - Female
KW  - Fibrinogen
KW  - drug effects
KW  - Glucose
KW  - metabolism
KW  - Heart Diseases
KW  - epidemiology
KW  - Humans
KW  - Insulin
KW  - Medroxyprogesterone Acetate
KW  - Middle Aged
KW  - Postmenopause
KW  - Risk Factors
KW  - Systole
KW  - Weight Gain
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
ER  -